Kriss Myers
Family Medicine · Azle, TXNPI 1902876972
Payments from drug & device makers
Across 468 payments — averaging $14.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$810
- GSK$710
- Pfizer$677
- AstraZeneca$620
- Amarin Pharma, Inc.$470
- Novo Nordisk$407
- plus $3K from 32 others
What the payments were for
- Food & beverage$6,584100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 60 | $810 |
| GSK | 40 | $710 |
| Pfizer | 55 | $677 |
| AstraZeneca | 39 | $620 |
| Amarin Pharma, Inc. | 39 | $470 |
| Novo Nordisk | 42 | $407 |
| Sanofi-aventis U.S. LLC | 19 | $379 |
| Boehringer Ingelheim | 29 | $335 |
| Amgen(2 entities) | 14 | $220 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 15 | $212 |
| Astellas Pharma US Inc | 10 | $156 |
| Tris Pharma Inc | 10 | $153 |
| Jazz Pharmaceuticals Inc. | 9 | $150 |
| Sunovion Pharmaceuticals Inc. | 16 | $145 |
| Johnson & Johnson(2 entities) | 9 | $131 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $122 |
| Shire North American Group Inc | 6 | $83 |
| Novartis | 4 | $80 |
| Cleerly, Inc. | 2 | $71 |
| Lilly USA, LLC | 5 | $65 |
| Eisai Inc. | 4 | $63 |
| Harmony Biosciences LLC | 3 | $48 |
| Genentech USA, Inc. | 3 | $47 |
| Mylan Specialty L.p. | 3 | $42 |
| Merck | 3 | $41 |
| Adlon Therapeutics L.p. | 3 | $40 |
| UCB, Inc. | 2 | $35 |
| Ironshore Pharmaceuticals Inc. | 2 | $35 |
| Si-bone, Inc. | 2 | $30 |
| Avanir Pharmaceuticals, Inc. | 2 | $29 |
| Strongbridge US Inc. | 1 | $28 |
| Abbott | 1 | $28 |
| Exact Sciences | 1 | $27 |
| Kowa Pharmaceuticals America, Inc. | 2 | $27 |
| Sanofi Pasteur Inc. | 2 | $26 |
| IBSA Pharma Inc. | 1 | $21 |
| Biohaven Pharmaceuticals, Inc. | 1 | $17 |
| Radius Health, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRELEGY ELLIPTA$249
- AREXVY$121
- SOLIQUA 100/33$121
How this compares
$6,590 in reported general payments places this provider in the 85th percentile of 8,760 family medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50 | 11 | $55,172 |
| EliquisApixaban | 31 | $33,390 |
| OzempicSemaglutide | 14 | $18,036 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 11 | $5,242 |
| SynthroidLevothyroxine Sodium | 17 | $2,042 |
| Rosuvastatin Calcium | 82 | $1,037 |
| Ezetimibe | 24 | $1,023 |
| Bupropion XlBupropion Hcl | 15 | $942 |
| Testosterone Cypionate | 12 | $751 |
| Levothyroxine Sodium | 37 | $521 |
| Eszopiclone | 16 | $401 |
| Tamsulosin Hcl | 18 | $397 |
| Gabapentin | 20 | $359 |
| Lisinopril | 24 | $340 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 18 | $326 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Gammagard Liquid | $122 | $55,17211 claims |
| PfizerEliquis | $677 | $33,39031 claims |
| Novo NordiskOzempic | $407 | $18,03614 claims |
| GSKAnoro Ellipta | $710 | $5,24211 claims |
| AbbVieSynthroid | $810 | $2,04217 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Azle
- Douglas DenhamSan Antonio$68.5M
- Vicki MillerPasadena$58.3M
- Hareshkumar BogharaDesoto$30.3M
- Earl MartinTomball$30.1M
- Lisa HollowayHouston$30.1M
- William SegerFort Worth$27.5M
- Veronica FragosoHouston$24.5M
- Joel SolisMcAllen$21.1M
- George AtieeSan Antonio$19.9M
- Bonnie ColvilleHouston$19.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.